Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Gossamer Bio (GOSS) Operating Expenses (2022 - 2025)

Historic Operating Expenses for Gossamer Bio (GOSS) over the last 4 years, with Q3 2025 value amounting to $62.4 million.

  • Gossamer Bio's Operating Expenses rose 4380.05% to $62.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $204.9 million, marking a year-over-year increase of 1500.39%. This contributed to the annual value of $174.6 million for FY2024, which is 497.34% down from last year.
  • Gossamer Bio's Operating Expenses amounted to $62.4 million in Q3 2025, which was up 4380.05% from $50.3 million recorded in Q2 2025.
  • Gossamer Bio's 5-year Operating Expenses high stood at $62.4 million for Q3 2025, and its period low was $40.5 million during Q3 2023.
  • Its 4-year average for Operating Expenses is $49.1 million, with a median of $47.9 million in 2023.
  • In the last 5 years, Gossamer Bio's Operating Expenses tumbled by 2772.35% in 2023 and then soared by 4380.05% in 2025.
  • Gossamer Bio's Operating Expenses (Quarter) stood at $54.4 million in 2022, then dropped by 9.81% to $49.0 million in 2023, then fell by 7.18% to $45.5 million in 2024, then surged by 37.14% to $62.4 million in 2025.
  • Its Operating Expenses was $62.4 million in Q3 2025, compared to $50.3 million in Q2 2025 and $46.7 million in Q1 2025.